Actively Recruiting
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Led by Regeneron Pharmaceuticals · Updated on 2026-04-17
20
Participants Needed
9
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.
CONDITIONS
Official Title
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Received at least 1 dose of treatment with vonsetamig in study R5459-RT-1944 [NCT05092347].
- Received a kidney transplant after acceptable crossmatching while enrolled in study R5459-RT-1944.
- Willing and able to comply with clinic visits and study-related procedures.
- Provide informed consent signed by the study patient or legally acceptable representative.
You will not qualify if you...
- There are no exclusion criteria for this study.
Note: Other protocol-defined inclusion/exclusion criteria may apply.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
Actively Recruiting
2
University of California Irvine
Orange, California, United States, 92868
Actively Recruiting
3
Connie Frank Transplant Center at UCSF
San Francisco, California, United States, 94143
Actively Recruiting
4
Yale University of Medicine
New Haven, Connecticut, United States, 06520
Actively Recruiting
5
Comprehensive Transplant Center
Chicago, Illinois, United States, 60611
Actively Recruiting
6
John Hopkins Hospital
Baltimore, Maryland, United States, 21224
Actively Recruiting
7
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
8
New York University Langone Health
New York, New York, United States, 10016
Actively Recruiting
9
Penn Transplant Institute
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
C
Clinical Trials Administrator
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here